Aprepitant Capsule IP 125/80 Mg

Essentials Pharma

MRP RS

Aprepitant Capsule IP 125/80 Mg is an antiemetic medicine containing Aprepitant, a selective NK1 receptor antagonist used for the prevention of chemotherapy-induced nausea and vomiting (CINV). It is commonly used as part of a combination antiemetic regimen with other medicines such as a 5-HT3 antagonist and corticosteroid, according to the prescribed chemotherapy protocol. The 125/80 mg capsule regimen is designed for use around chemotherapy cycles, with the dosing schedule determined by the treating physician based on the chemotherapy regimen and patient requirements. Aprepitant helps prevent both acute and delayed phases of chemotherapy-induced nausea and vomiting. It is suitable for use in oncology hospitals, cancer-care centres and clinical settings under the supervision of qualified healthcare professionals. Key Features:- Generic Name: Aprepitant Strength: 125 mg / 80 mg Dosage Form: Capsules Pharmacopoeial Standard: IP Drug Class: NK1 Receptor Antagonist Therapeutic Category: Antiemetic / Supportive Oncology Care Primary Use: Prevention of chemotherapy-induced nausea and vomiting Regimen: 125 mg and 80 mg capsules used according to the prescribed chemotherapy schedule Clinical Use: Suitable for oncology and chemotherapy-supportive care Prescription Medicine: To be used according to medical advice Professional Use: Appropriate for hospital and clinical oncology settings